Antibody DISCONTINUED
Application Notes
Specification | Recommendation |
---|---|
Recommended Dilution (Conc) | 1:25-1:50 |
Pretreatment | EDTA Buffer pH 8.0 |
Incubation Parameters | 30 min at RoomTemperature |
Prior to use, inspect vial for the presence of any precipitate or other unusual physical properties. These can indicate that the antibody has degraded and is no longer suitable for patient samples. Please run positive and negative controls simultaneously with all patient samples to account and control for errors in laboratory procedure. Use of methods or materials not recommended by enQuire Bio including change to dilution range and detection system should be routinely validated by the user.
CD25 Information for Pathologists
CD25 General Information | |
---|---|
Alternate Names | |
Molecular Weight | |
30.8 kDa | |
Chromosomal Location | |
p15.1 [chr: 10] [chr_start: 6010689] [chr_end: 6062370] [strand: -1] | |
Curated Database and Bioinformatic Data | |
Gene Symbol | IL2RA |
Entrez Gene ID | 3559 |
RefSeq Protein Accession(s) | NP_000408; NP_001295171; NP_001295172 |
RefSeq mRNA Accession(s) | NM_000417; NM_001308242; NM_001308243 |
RefSeq Genomic Accession(s) | NC_000010; NG_007403 |
UniProt ID(s) | P01589 |
PharmGKB ID(s) | PA29828 |
KEGG Gene ID(s) | hsa:3559 |
Associated Diseases (KEGG IDs) | Diabetes mellitus, insulin-dependent, 10 (IDDM10) [MIM:601942]: A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:17676041}. Disease susceptibility is associated with variations affecting the gene represented in this entry.; Immunodeficiency 41 with lymphoproliferation and autoimmunity (IMD41) [MIM:606367]: A disorder of immune dysregulation characterized by recurrent viral, fungal, and bacterial infections, lymphadenopathy, and variable autoimmune features, such as autoimmune enteropathy and eczematous skin lesions. {ECO:0000269|PubMed:23416241, ECO:0000269|PubMed:24116927}. The disease is caused by mutations affecting the gene represented in this entry. |
General Description of CD25 . | |
CD25, or interleukin 2 (IL2) receptor alpha (IL2RA), and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. CD25 is the alpha chain of the IL-2 receptor. It is a type I transmembrane protein present on activated T cells and activated B cells. Normally an integral-membrane protein, soluble CD25 has been isolated and determined to result from extracellular proteolysis. CD25 also appears to be a reliable immunohistochemical marker for the discrimination of neoplastic from normal/reactive mast cells, with potential as a diagnostic tool in systemic mastocytosis. CD25 is also expressed on hairy cell leukemia |
There are no reviews yet.